United States· US:50090-7851_bba25161-4506-4e35-a98a-deff97b5d23f

terazosin

A medicinal product containing terazosin hydrochloride, registered in United States by A-S Medication Solutions.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedterazosinATC—REGISTER NO.US:50090-7851_bba2516…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TERAZOSIN HYDROCHLORIDE
Manufacturer
A-S Medication Solutions
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    50090-7851-0
  • ndc11
    50090-7851-1
  • ndc11
    5009078510
    30 CAPSULE in 1 BOTTLE (50090-7851-0)
  • ndc11
    5009078511
    90 CAPSULE in 1 BOTTLE (50090-7851-1)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Terazosin hydrochloride in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terazosin hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Uroflo, Vicard
  • Belgium · Hytrin, Terazosab
  • Czechia · Kornam
  • Germany · Heitrin, Tera Tad
  • Denmark · Sinalfa
  • Spain · Alfaprost, Mayul
  • France · Dysalfa, Hytrine
  • United Kingdom (Northern Ireland) · Hytrin, Terazosin
  • Greece · Hytrin
  • Hungary · Setegis
  • Ireland · Hytrin
  • Italy · Itrin, Prostatil
  • Luxembourg · Hytrin, Terazosab
  • Netherlands · Hytrin, Terazosine Accord
  • Norway · Sinalfa
  • Poland · Hytrin, Kornam
  • Portugal · Hytrin
  • Sweden · Sinalfa
  • Slovenia · Kornam
  • Slovakia · Kornam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fef72bd0-e0e2-4628-a160-8371a6243313
GET /v1/drugs/fef72bd0-e0e2-4628-a160-8371a6243313?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "1",
  "substance": "TERAZOSIN HYDROCHLORIDE",
  "productndc": "50090-7851",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA075614",
  "marketing_category": "ANDA"
}

See everything about terazosin hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.